Author

M Karen Newell Rogers

Observed name: M. Karen Newell Rogers

Institution: Texas A&M University

Observed institutions: Tulane University, Ahmadu Bello University, Cedars-Sinai Medical Center, Barrow Neurological Institute, Texas A&M University System, Baylor Scott & White Medical Center - Temple, Advocate Illinois Masonic Medical Center, Scott & White Memorial Hospital, Texas A&M University

OpenAlex ID: A5067558671

The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition

2012 · Chander Peddaboina, Daniel Jupiter, et al. · BMC Cancer · 78

Racial Disparities in Malignant Primary Brain Tumor Survival in Texas From 1995 to 2013

2020 · Solomon Ambe, Kristopher A Lyon, et al. · Cureus · 8

EXTH-89. Precision Targeting of PI3K/mTOR in Diffuse Midline Glioma: GCT007 as a Novel Brain-Penetrant PIK3CA Inhibitor

2025 · Evangeline Jackson, Ryan Duchatel, et al. · Neuro-Oncology

DMG-64. PI3 Kinase and Checkpoint Inhibition: A Potentially Novel Therapeutic Strategy for Diffuse Intrinsic Pontine and Diffuse Midline Glioma

2025 · M Karen Newell Rogers, Matt Dun, et al. · Neuro-Oncology Pediatrics

768 PI3 kinase and checkpoint inhibition: sexual dimorphism in a native model of glioblastoma (GBM)

2024 · Ali Jalali, Abu Bakar Siddik, et al. · Journal for ImmunoTherapy of Cancer

Works count: 5

Citation count: 86

H-index: 2

I10-index: 1